Evidence map›Paper›PMID 19005235›Full record

ArticleJournal of biosciences2008

Purification and molecular cloning of a new galactose-specific lectin from Bauhinia variegata seeds.

Luciano S Pinto, Celso S Nagano, Taianá M Oliveira, Tales R Moura, Alexandre H Sampaio, Henri Debray, Vicente P Pinto, Odir A Dellagostin, Benildo S Cavada

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of biosciences, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 45 citations in OpenAlex.

  1. Novel Lectins fromACS omega · 2025
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Luciano S PintoCentro de Biotecnologia, Universidade Federal de Pelotas, Pelotas, RS, Brazil. dmpluc@ufpel.edu.br
Celso S Nagano
Taianá M Oliveira
Tales R Moura
Alexandre H Sampaio
Henri Debray
Vicente P Pinto
Odir A Dellagostin
Benildo S Cavada
Universidade Federal do Ceará · BRUniversidade Federal de Pelotas · BRÉcole Nationale Supérieure de Chimie de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new galactose-specific lectin was purified from seeds of a Caesalpinoideae plant, Bauhinia variegata, by affinity chromatography on lactose-agarose. Protein extracts haemagglutinated rabbit and human erythrocytes (native and treated with proteolytic enzymes), showing preference for rabbit blood treated with papain and trypsin. Among various carbohydrates tested, the lectin was best inhibited by D-galactose and its derivatives, especially lactose. SDS-PAGE showed that the lectin, named BVL, has a pattern similar to other lectins isolated from the same genus, Bauhinia purpurea agglutinin (BPA). The molecular mass of BVL subunit is 32 871 Da, determined by MALDI-TOF spectrometry. DNA extracted from B.variegata young leaves and primers designed according to the B. purpurea lectin were used to generate specific fragments which were cloned and sequenced, revealing two distinct isoforms. The bvl gene sequence comprised an open reading frame of 876 base pairs which encodes a protein of 291 amino acids. The protein carried a putative signal peptide. The mature protein was predicted to have 263 amino acid residues and 28 963 Da in size.

Indexed as

Amino Acid SequenceAnimalsBauhiniaGalactoseHemagglutinationHumansMolecular Sequence DataPlant LectinsRabbitsSeedsSequence Analysis, DNASpecies SpecificityGalactosePlant Lectins

Identifiers

PMID19005235
OpenAlexW2099431713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.